Agency Forms Undergoing Paperwork Reduction Act Review, 13053-13054 [2014-04970]
Download as PDF
<![CDATA[
13053
Federal Register / Vol. 79, No. 45 / Friday, March 7, 2014 / Notices
Background and Brief Description
implementation of a proposed
Commission action.
*
*
*
*
*
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
Shelley E. Garr,
Deputy Secretary.
[FR Doc. 2014–05042 Filed 3–5–14; 11:15 am]
BILLING CODE 6715–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–14–14CL]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
An Investigation of Lung Health at an
Indium-Tin Oxide Production Facility—
New—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
The mission of the National Institute
for Occupational Safety and Health
(NIOSH) is to promote safety and health
at work for all people through research
and prevention. The Occupational
Safety and Health Act, Public Law 91–
596 (section 20[a][1]), authorizes NIOSH
to conduct research to advance the
health and safety of workers. NIOSH is
proposing to conduct a study regarding
the lung health of workers at an indiumtin oxide production facility.
Indium-tin oxide (ITO) is a sintered
material used in the manufacture of
devices such as liquid crystal displays,
touch panels, solar cells, and
architectural glass. Indium lung disease
is a novel, potentially fatal industrial
disease that has occurred in workers
making, using, or recycling ITO. This
project aims to understand and prevent
this occupational lung disease by
investigating the relationship between
exposure and lung health among current
ITO manufacturing workers.
CDC requests Office of Management
and Budget (OMB) approval to collect
standardized information from current
employees of the ITO production
facility through an informed consent
document, an interviewer-administered
questionnaire, and a contact information
form. As part of the same project,
employees will be offered the
opportunity to participate in medical
testing and personal air sampling.
The questionnaire will collect contact
information, demographic information,
respiratory symptoms and diagnoses,
work history, and cigarette smoking
history. The questionnaire will allow
NIOSH to report individual medical test
results to each participant and to
analyze aggregate data from the
workforce to determine risk factors for
abnormal lung health indices derived
from the medical test results. The
individual results will be used by
employees and their personal
physicians to make medical decisions,
such as whether to pursue additional
testing. The aggregate results will be
used by NIOSH, facility management,
and employees in ongoing efforts to
reduce exposures and monitor key
health indices.
For this study, we will recruit all
current employees of the ITO
production facility. Participation is
voluntary. We anticipate approximately
100 study participants. Employees who
wish to participate in the questionnaire
and medical testing will review and sign
an informed consent document.
Employees who wish to participate in
the personal air sampling and would
like to receive personal results will
complete a contact information form.
Participants who wish to release
medical records to NIOSH or to have
NIOSH release the results of our
medical testing to a personal physician
will need to complete the appropriate
records release forms.
The questionnaire will be
administered privately at the workplace
during normal working hours by trained
NIOSH staff. Employees who are not
available at the workplace during the
study will be offered the opportunity to
respond to the questionnaire at a later
date by telephone.
There are no costs to participants
other than their time.
The total estimated burden for the
one-time collection of data is 254 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Current ITO production facility employees .....
mstockstill on DSK4VPTVN1PROD with NOTICES
Type of respondents
Recruitment letter ...........................................
Consent to participate in a research study ....
Authorization to disclose health information ..
Indium facility questionnaire ...........................
Medical testing ...............................................
Script for collection of industrial hygiene
samples.
Personal air sampling results contact information form.
Exposure monitoring ......................................
VerDate Mar<15>2010
18:39 Mar 06, 2014
Jkt 232001
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
E:\FR\FM\07MRN1.SGM
Number of
responses per
respondent
Average
burden per
response
(in hours)
100
95
95
95
95
95
1
1
1
1
1
1
5/60
15/60
5/60
20/60
100/60
5/60
95
1
5/60
95
1
5/60
07MRN1
13054
Federal Register / Vol. 79, No. 45 / Friday, March 7, 2014 / Notices
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–04970 Filed 3–6–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–14LA]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, 1600
Clifton Road, MS D–74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
mstockstill on DSK4VPTVN1PROD with NOTICES
Proposed Project
Annual Survey of Colorectal Cancer
Control Activities Conducted by States
and Tribal Organizations—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
VerDate Mar<15>2010
18:39 Mar 06, 2014
Jkt 232001
Background and Brief Description
In July 2009, the Centers for Disease
Control and Prevention’s Division of
Cancer Prevention and Control, National
Center for Chronic Disease Prevention
and Health Promotion, funded the
Colorectal Cancer Control Program
(CRCCP) for a five-year period. Through
a competitive application process, 22
states and four tribal organizations
received cooperative agreement awards.
In 2010, three additional states were
funded, bringing the total number of
grantees to 29. The purpose of the
CRCCP is to promote colorectal cancer
(CRC) screening to increase populationlevel screening rates to 80% and,
subsequently, to reduce CRC incidence
and mortality (www.cdc.gov/cancer/
crccp/). The CRCCP includes two
program components: (1) CRC screening
of low-income, uninsured and
underinsured people (screening
provision) and (2) implementation of
interventions to increase populationlevel screening rates (screening
promotion).
The CRCCP is based on a socialecological framework that emphasizes
the implementation of evidence-based
strategies at the interpersonal,
organizational, community, and policy
levels. Grantees are strongly encouraged
to implement one or more of the five
evidence-based strategies that are
recommended in the Guide to
Community Preventive Services
(Community Guide;
www.thecommunityguide.org/cancer/
index.html ).
As a comprehensive, organized
screening program, the CRCCP supports
activities including program
management, partnership development,
public education and targeted outreach,
screening and diagnostic services,
patient navigation, quality assurance
and quality improvement, professional
development, data management and
utilization, and program monitoring and
evaluation. For clinical service delivery,
grantees fund health care providers in
their state or tribal organization to
deliver colorectal cancer screening,
diagnostic evaluation, and treatment
referrals for those diagnosed with
cancer. Through direct screening efforts
in the first three years of the CRCCP,
26,565 individuals were screened, 4,059
cases of precancerous polyps were
detected and removed, and 74 cancers
were diagnosed and treated.
The purpose of the proposed data
collection is to annually assess program
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
implementation, particularly related to
the use of evidence-based strategies. The
primary survey audience is CRCCP
program grantees (program directors or
managers); however, the survey will
also be administered to a comparison
group of states or tribes that do not
currently receive CRCCP funding.
Respondents for the non-CRCCP funded
survey group will be program directors
or managers from the National Breast
and Cervical Cancer Early Detection
Program (NBCCEDP), a comparable
group with whom the Centers for
Disease Control and Prevention (CDC)
has an established relationship.
The Web-based survey includes
questions about respondent background,
program activities, clinical service
delivery, monitoring and evaluation,
partnerships, training and technical
assistance needs, and program
management and integration. Questions
are of various types including
dichotomous and multiple response.
The estimated burden per response is 75
minutes. There are two versions of the
survey: One for CRCCP-funded states
and tribal organizations, and one for
states and tribal organizations that do
not currently receive CRCCP funding.
All information will be collected
electronically.
The assessment will enable CDC to
gauge progress in meeting CRCCP
program goals, identify implementation
activities, monitor efforts aimed at
impacting population-based screening,
identify technical assistance needs of
state, tribe and territorial health
department cancer control programs,
and identify implementation models
with potential to expand and transition
to new settings to increase program
impact and reach.
The assessment will also identify
successful activities that should be
maintained, replicated, or expanded as
well as provide insight into areas that
need improvement. Current CRCCP
funding is through June 2015, however,
CDC anticipates that the program will be
renewed. Data obtained from the
unfunded states or tribes will provide
comparison data to facilitate
identification of similarities or
differences, if any, in colorectal cancer
screening activities, including the use of
evidence-based strategies to promote
and provide cancer screening. OMB
approval is requested for three years.
Participation in the survey is voluntary
and there are no costs to respondents
other than their time.
E:\FR\FM\07MRN1.SGM
07MRN1
]]>Agencies
[Federal Register Volume 79, Number 45 (Friday, March 7, 2014)]
[Notices]
[Pages 13053-13054]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-04970]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-14-14CL]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
An Investigation of Lung Health at an Indium-Tin Oxide Production
Facility--New--National Institute for Occupational Safety and Health
(NIOSH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the National Institute for Occupational Safety and
Health (NIOSH) is to promote safety and health at work for all people
through research and prevention. The Occupational Safety and Health
Act, Public Law 91-596 (section 20[a][1]), authorizes NIOSH to conduct
research to advance the health and safety of workers. NIOSH is
proposing to conduct a study regarding the lung health of workers at an
indium-tin oxide production facility.
Indium-tin oxide (ITO) is a sintered material used in the
manufacture of devices such as liquid crystal displays, touch panels,
solar cells, and architectural glass. Indium lung disease is a novel,
potentially fatal industrial disease that has occurred in workers
making, using, or recycling ITO. This project aims to understand and
prevent this occupational lung disease by investigating the
relationship between exposure and lung health among current ITO
manufacturing workers.
CDC requests Office of Management and Budget (OMB) approval to
collect standardized information from current employees of the ITO
production facility through an informed consent document, an
interviewer-administered questionnaire, and a contact information form.
As part of the same project, employees will be offered the opportunity
to participate in medical testing and personal air sampling.
The questionnaire will collect contact information, demographic
information, respiratory symptoms and diagnoses, work history, and
cigarette smoking history. The questionnaire will allow NIOSH to report
individual medical test results to each participant and to analyze
aggregate data from the workforce to determine risk factors for
abnormal lung health indices derived from the medical test results. The
individual results will be used by employees and their personal
physicians to make medical decisions, such as whether to pursue
additional testing. The aggregate results will be used by NIOSH,
facility management, and employees in ongoing efforts to reduce
exposures and monitor key health indices.
For this study, we will recruit all current employees of the ITO
production facility. Participation is voluntary. We anticipate
approximately 100 study participants. Employees who wish to participate
in the questionnaire and medical testing will review and sign an
informed consent document. Employees who wish to participate in the
personal air sampling and would like to receive personal results will
complete a contact information form. Participants who wish to release
medical records to NIOSH or to have NIOSH release the results of our
medical testing to a personal physician will need to complete the
appropriate records release forms.
The questionnaire will be administered privately at the workplace
during normal working hours by trained NIOSH staff. Employees who are
not available at the workplace during the study will be offered the
opportunity to respond to the questionnaire at a later date by
telephone.
There are no costs to participants other than their time.
The total estimated burden for the one-time collection of data is
254 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Current ITO production facility Recruitment letter...... 100 1 5/60
employees.
Consent to participate 95 1 15/60
in a research study.
Authorization to 95 1 5/60
disclose health
information.
Indium facility 95 1 20/60
questionnaire.
Medical testing......... 95 1 100/60
Script for collection of 95 1 5/60
industrial hygiene
samples.
Personal air sampling 95 1 5/60
results contact
information form.
Exposure monitoring..... 95 1 5/60
----------------------------------------------------------------------------------------------------------------
[[Page 13054]]
Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-04970 Filed 3-6-14; 8:45 am]
BILLING CODE 4163-18-P
